Older Drug Better Than New For Blood Cell Disorder

The older generic drug hydroxyurea, if combined with a small dose of aspirin and given to people with thrombocythemia, is more effective in preventing serious bleeding and other complications than the newer and more expensive Agrylin, according to a study. Agrylin, also known as anagrelide, is made by Roberts Pharmaceuticals, which merged with Shire Pharmaceuticals Group in 1999.

Back to news